Status:

UNKNOWN

Blood Flow Restriction With Aerobic Exercise in Frail Older Adults

Lead Sponsor:

National Cheng Kung University

Conditions:

Rehabilitation

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

Background:Frailty is most often defined as a syndrome of physiological decline in late life, characterized by marked vulnerability to adverse health outcomes. Exercise intervention including aerobic ...

Eligibility Criteria

Inclusion

  • more than one positive item of Fried frailty phenotype assessment
  • able to walk more than 8 meters independently
  • can understand and follow more than three-step order

Exclusion

  • severe hypertension (\>160/100 mmHg)
  • cardiovascular disease, such as myocardial infarction, New York Heart Association class III or IV heart failure, pulmonary hypertension
  • deep vein thrombosis or peripheral vascular disease
  • peripheral neuropathy due to diabetes
  • neuromuscular diseases, such as stroke, Parkinson's disease, etc.

Key Trial Info

Start Date :

December 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06155227

Start Date

December 20 2023

End Date

December 1 2025

Last Update

December 26 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Physical Therapy

Tainan, Taiwan, 701

Blood Flow Restriction With Aerobic Exercise in Frail Older Adults | DecenTrialz